By Category

• Clinical Trial Results (8)
• Closing Bell (22)
• Company Shakeups (14)
• FDA/Regulatory (13)
• Financial (7)
• Intellectual Property (4)
• IPO (3)
• License/Partnership (15)
• M&A (27)
• Restructurings and Layoffs (2)
• Sales/Marketing (8)
• Science (2)
• Statistics (4)
• Uncategorized (16)
• Venture Capital (16)
• Video (5)

By Month

• August 2008 (42)
• July 2008 (13)
• June 2008 (37)
• May 2008 (37)
• April 2008 (17)
• March 2008 (8)

By Tag

• accounting
• acquisition
• astrazeneca
• avant
• bapineuzumab
• BMS
• Bristol-Myers Squibb
• Business
• Clinical trial
• Closing Bell
• cytori
• Elan
• fda
• financial accounting
• financial analysis
• financing
• Food and Drug Administration
• funding
• genentech
• Genzyme
• GlaxoSmithKline
• GSK
• income statements
• infinity
• IPO
• javelin
• license
• M&A
• merger
• MS
• Multiple Sclerosis
• myriad
• Novartis
• pfizer
• private equity
• Roche
• sequenom
• stocks
• Sucampo
• Takeda
• VC
• Venture Capital
• venture funding
• Video
• Wyeth